ArticleMaterials (Basel, Switzerland)2022

Development and Characterization of PEGDA Microneedles for Localized Drug Delivery of Gemcitabine to Treat Inflammatory Breast Cancer.

Ahmed Alafnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.